NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.25% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.93% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.90% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.85% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.83% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.54% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.44% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.37% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.35% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.32% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.31% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.26% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.21% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 2.05% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.94% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.84% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.73% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.56% |